RAPGEF1 (Rap Guanine Nucleotide Exchange Factor 1), also known as C3G or GRF2, is a guanine nucleotide exchange factor (GEF) that activates small GTPases like Rap1. These GTPases regulate processes such as cell adhesion, migration, and differentiation . The RAPGEF1 antibody is designed to bind specifically to this protein, facilitating its detection and functional analysis in experimental settings .
ERK1/2 Pathway Activation: RAPGEF1 mediates inorganic phosphate (Pi)-induced ERK1/2 phosphorylation via a Rap1/B-Raf/Mek1/2 cascade in vascular smooth muscle cells, influencing phenotype changes .
miR-203 Interaction: RAPGEF1 is a direct target of miR-203, which suppresses keratinocyte proliferation and promotes differentiation .
Cancer:
RAPGEF1 exhibits dual roles in tumorigenesis, acting as either an oncogene or tumor suppressor depending on context :
Neurological and Developmental Roles:
Zebrafish studies show that RAPGEF1 is essential for early embryonic morphogenesis, including brain and somite development .
Western Blot: Validated for detecting RAPGEF1 in human, mouse, and rat tissues (e.g., mouse liver) .
Immunohistochemistry: Used to localize RAPGEF1 in paraffin-embedded human pancreas tissue .
Functional Studies: Silencing RAPGEF1 with siRNA reduces ERK1/2 phosphorylation and alters gene expression in vascular cells .
RAPGEF1 undergoes extensive phosphorylation and ubiquitination, modulating its activity: